The "Spanish" influenza pandemic of 1918 -1919 stands as the deadliest single event in recorded human history, killing approximately 50 million people. The cause of the 1918 pandemic and the determinants of its severity remained one of the most discussed medical mysteries throughout most of the 20th century. PCR technology, however, made it possible to recover fragments of viral RNA from preserved tissues and, through "reverse genetics," to reconstruct the 1918 virus. Remarkably, viral RNA fragments from a few victims are yielding novel insights into influenza virus biology and provide important information about how to control such pandemics.
This project raised the question of whether it was wise to recreate one of the deadliest infectious agents in history. However, senior U.S. government scientists and offıcials at the Department of Health and Human Services concluded that such research could play an important role in pandemic influenza preparedness. Thus, the public can clearly benefıt from research involving "dual use" pathogens, provided that biosafety and biosecurity issues are adequately addressed.
Although the pandemic influenza viruses of 1957, 1968, and 2009 Analysis of the structure of the 1918 virus HA protein provides a better understanding of viral receptor binding and host adaptation and insights into structure-based vaccine design. Conserved protein motifs on the 1918 virus HA could be the basis for vaccines that provide broad, crossreactive immunity to IAV of different subtypes.
The genomic sequence of the 1918 influenza virus yields clues into how pandemic strains emerge, including the possible role of intermediate hosts. Avian IAV strains have a higher guanine-cytosine (GC) content than do viral strains adapted to humans, suggesting the 1918 pandemic virus possibly derived from an avian virus prior to its adaptation to humans.
Because all three subsequent pandemic viruses contain gene segments derived from the 1918 "founder" virus, the past 94 years can be considered a single "pandemic era." Going back more than 500 years, evidence suggests even earlier pandemic influenza eras and that extremely uncommon IAV host switch events may trigger influenza pandemic eras. Incorporating one or more novel gene segments into available postpandemic viruses allows these viruses to escape population immunity while retaining those properties associated with human adaptation, implying that viral surveillance needs to look in two directions simultaneously: for novel influenza viruses that emerge in humans or other mammals from the avian IAV gene pool and for existing human-and mammal-adapted viruses that may be involved in gene segment recycling.
In some ways, the 1918 sequencing project served as a springboard for expanding publicly available IAV genome sequences. While practical integration of this new information into surveillance and public health preparedness is daunting, it is leading us to a greater understanding of the patterns of influenza virus emergence and evolution. These insights should lead to an enhanced ability to anticipate, detect, and respond to the emergence of novel influenza viruses.
The fully reconstructed 1918 pandemic virus is pathogenic-without prior adaptation-in mice, ferrets, and macaques (N.B., while mice are commonly used in experimental influenza studies, disease and effıcient viral replication in mice are not generally observed with unadapted human IAV strains). To combat infectious diseases, it is necessary to understand the molecular basis of each pathogen's phenotypic properties, including infectivity, cell tropism, replication, immunogenicity, pathogenicity, and transmissibility. Numerous pathogenicity studies have been performed with the 1918 virus in animal models, including both "gain-of-function" and "loss-of-function" studies using chimeric influenza viruses carrying one or more 1918 viral genes of interest, expressed on less pathogenic viral "reference" backgrounds. Such studies, while seeking primarily to answer questions about the 1918 pandemic, have provided insights into possible mechanisms of pathogenicity and host adaptation of future pandemic strains.
Although the innate virulence of the 1918 influenza virus is polygenic, proteins encoded by the HA and the three polymerase gene segments play key roles. Despite lacking an obvious single virulence factor, influenza viruses expressing the 1918 virus HA are unquestionably pathogenic in mice and ferrets. In a similar manner, chimeric influenza viruses expressing each of the four known pandemic virus HA proteins are also pathogenic in mice. However, viruses expressing the 1918 viral HA induce a unique inflammatory response in mice and ferrets.
Studies with the reconstructed 1918 virus also provide a more nuanced understanding of host adaptation. For example, some mutations associated with human adaptation in the 1918 virus are not seen in lineages of other human-or mammalian-adapted influenza viruses. Although understanding virus transmissibility is complicated by the lack of ideal animal models, experiments with the 1918 virus show that changes in both the HA receptor-binding domain and the polymerase PB2 protein correlate with ferret transmissibility.
Although IAV adapted to avian hosts specifı-cally bind ␣2-3 sialic acid linkages, a few critical mutations in the HA receptor-binding domain can alter this specifıcity to cellular glycans terminating in ␣2-6-linked sialic acids. Only two mutations in the receptor-binding domain completely alter viral specifıcity from an avianadapted to a human-adapted confıguration. But, both ␣2-3 and ␣2-6 receptor-binding variants of the 1918 virus circulated during the fırst year of that pandemic. Does this reflect early evolution from an avian-to a mammalian-adapted virus? Did pandemic viral quasispecies contain both variants, and if so, was this a reflection of different cell tropisms along the human respiratory tract?
Pathological changes associated with fatal influenza pneumonias and the role that secondary bacterial infection plays raise questions about how viral infections and host immune responses potentiate secondary bacterial infections. These fındings have important implications for clinical management and public health control.
The unusual peak of mortality among 20-to 40-year-olds is one of the 1918 pandemic's most puzzling features. Pathogenesis studies with the 1918 virus in mice and nonhuman primates support the hypothesis that the host inflammatory response is involved in disease progression. The 1918 influenza virus is effıcient at suppressing innate antiviral responses while concurrently activating potent proinflammatory responses.
Virology is fınding a wealth of important information hidden in very degraded RNA viral fragments from the 1918 pandemic, a public health benchmark for medical historians as they seek to understand events that were once incomprehensible. However important it is to understand the past, it is the promise of managing the future that we insist is most compelling. These studies of the 1918 pandemic virus are opening a once-locked door that will allow us to better understand the future. Although concerns about dual use research were considered from the outset of this project, reconstruction of the pandemic virus led to no adverse events. On the contrary, the benefıts are obvious and manifold and have demonstrably contributed to the betterment of human health.
